Andrew Parker

1.6k citations
15 papers · 522 indexed · h-index 9
Topics
Head and Neck Cancer Studies (2 papers)Medical Imaging and Pathology Studies (2 papers)Advanced Breast Cancer Therapies (1 paper)

In The Last Decade

Andrew Parker

15 papers receiving 516 citations

Peers

Andrew Parker
Comparison fields: 5 of 75
  • Immunology 143
  • Oncology 138
  • Molecular Biology 135
  • Pulmonary and Respiratory Medicine 99
  • Neurology 82
Replace Suresh Mohan with:
Suresh Mohan United States
Tetsuo Yanagawa Japan
Levi Ledgerwood United States
Thomas Trenkle Germany
Shigetaka Yanagisawa Japan
H.-J. Holzhausen Germany
Nasrin Yazdani Iran
U. Ganzer Germany
Noboru Ando Japan
Richard M. Tempero United States
Andrew Parker relative to Suresh Mohan United States Suresh Mohan's profile →
Citations per field
00.5×1.5×2.0×
Suresh Mohan · 1×
Citations per year

Countries citing papers authored by Andrew Parker

Since Specialization
Citations

This map shows the geographic impact of Andrew Parker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Parker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Parker more than expected).

Fields of papers citing papers by Andrew Parker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Parker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Parker. The network helps show where Andrew Parker may publish in the future.

Co-authorship network of co-authors of Andrew Parker

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Parker. A scholar is included among the top collaborators of Andrew Parker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Parker. Andrew Parker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 1
2 39
3 3
4 49
5 1
6 15
7 83
8 11
9 6
10 119
11 88
12 66
13 2
14 6
15 33

About Andrew Parker

Andrew Parker is a scholar working on Otorhinolaryngology, Developmental Neuroscience and Pulmonary and Respiratory Medicine, having authored 15 papers that have together received 522 indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (2 papers), Medical Imaging and Pathology Studies (2 papers) and Advanced Breast Cancer Therapies (1 paper). The work is most often cited by research in Otorhinolaryngology (50 citations), Immunology (143 citations) and Neurology (82 citations). Andrew Parker has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Maziar Sadri, Jeremy McMahon, Akira Nguyen, Peter I. Croucher, Tri Giang Phan, Alexander Swarbrick, Hugh A. Pearson, Mark Dallas, John P. Boyle and Chris Peers. Their work appears in journals such as Nature Communications, Scientific Reports and Journal of Neurochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026